Company Search:
Advanced Search
Sponsored Links
Geron Corporation Company Snapshot
Geron Corporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Geron with three other companies in this sector in the United States: Ptc Therapeutics Inc (2015 sales of $36.77 million of which 100% was Bio Pharmaceutical), Juniper Pharmaceuticals Inc ($37.56 million of which 69% was Product), and Integrated Biopharma, Inc. ($37.49 million ).

Sales Analysis. Sales increased substantially in 2015: During the year ended December of 2015, sales at Geron were $36.37 million. This is an increase of 3,054.5% versus 2014, when the company's sales were $1.15 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Geron Corporation
  Stock Performance Chart for Geron Corporation
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 2.10
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks -7.9%  
4 Weeks -1.9%   52 Weeks -26.6%  
Geron Corporation Key Data:
  Ticker: GERN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 36,371,000
(Year Ending Jan 2016).
Employees: 20
  Currency: U.S. Dollars Market Cap: 334,204,697
  Fiscal Yr Ends: December Shares Outstanding: 159,145,094
  Share Type: Common Closely Held Shares: 806,560
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.